97575104 - LION

Information

• Trademark
• 97575104

• Source

• Serial Number

  97575104

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  September 01, 2022
  2 years ago

• Transaction Date

  August 30, 2024
  22 days ago

• Status Date

  August 28, 2024
  24 days ago

• Location Date

  February 28, 2024
  6 months ago

• Status Code

  760

• Current Location

  TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  WLODARCZYK, CAROLYN A

• Attorney Docket Number

  201953010702

  Attorney Name

  Draeke H. Weseman

  Law Office Assigned Location Code

  L90

• Owners

  • HDT Bio Corp.

Case File Statements

• GS0051: Medical, biological, and pharmaceutical preparations for the treatment of cancer, infectious diseases, and rare and orphan diseases; Therapeutic preparations in the nature of vaccines or nucleic acid, protein or small-molecule medicines, delivered via intramuscular injections, intravenous injections, inhalation, transdermal, intradermal, or intranasal methods, for the treatment of cancer, infectious diseases, and rare and orphan diseases; Immunotherapeutics, namely, pharmaceutical preparations in the nature of vaccines and nucleic acid, protein or small-molecule medicines for the treatment of cancer, infectious diseases, and rare and orphan diseases; Nanoparticles and nanoparticle formulations in the nature of active pharmaceutical ingredient delivery agents in the form of nanoparticles that facilitate the delivery of medical, biological, pharmaceutical, and therapeutic preparations for the treatment of cancer, infectious diseases, and rare and orphan diseases; Pharmaceutical preparations, namely, lipid-enabled drug delivery systems for nucleic acid, protein or small-molecule medicines comprising small interfering RNA, messenger RNA, antisense, microRNA, DNA, or cDNA oligotherapeutic, protein therapeutic agents, or small molecules to enable the targeting of any gene in the human genome, modulating immune response, or vaccination, sold to pharmaceutical companies as an integral component for use in the further manufacture of pharmaceutical preparations for the treatment of a wide variety of diseases, including cancer, infectious diseases, and rare and orphan diseases; Vaccines; Veterinary vaccines

Case File Event Statements

• 7/13/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/5/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/9/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/17/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 7/13/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/13/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/12/2023 - 11 months ago

  7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 10/12/2023 - 11 months ago

  8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 1/13/2024 - 8 months ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/13/2024 - 8 months ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/15/2024 - 8 months ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/28/2024 - 6 months ago

  12 - FINAL REFUSAL WRITTEN Type: CNFR

• 2/28/2024 - 6 months ago

  13 - FINAL REFUSAL E-MAILED Type: GNFR

• 2/28/2024 - 6 months ago

  14 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 4/26/2024 - 4 months ago

  16 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 8/28/2024 - 24 days ago

  20 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 8/28/2024 - 24 days ago

  22 - TEAS AMENDMENT OF USE RECEIVED Type: EAAU

• 4/26/2024 - 4 months ago

  15 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 8/28/2024 - 24 days ago

  21 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 8/28/2024 - 24 days ago

  17 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF

• 8/28/2024 - 24 days ago

  18 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 8/28/2024 - 24 days ago

  19 - EX PARTE APPEAL-INSTITUTED Type: EXPI